USP19 AS A NOVEL THERAPEUTIC TARGET FOR IMPEDING PROPAGATION AND SECRETION OF TAU IN PARKINSON'S DISEASE
$999,531FY2018Department of the ArmyDOD
The Research Institute Of The Mcgill University Health Centre
The Research Institute Of The Mcgill University Health Centre